These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8805029)

  • 1. Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide.
    Gale EA
    Horm Res; 1996; 45 Suppl 1():39-43. PubMed ID: 8805029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theory and practice of nicotinamide trials in pre-type 1 diabetes.
    Gale EA
    J Pediatr Endocrinol Metab; 1996; 9(3):375-9. PubMed ID: 8887146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of type 1 diabetes: from the view point of beta cell damage.
    Kawasaki E; Abiru N; Eguchi K
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S27-32. PubMed ID: 15563975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide in type 1 diabetes. Mechanism of action revisited.
    Kolb H; Burkart V
    Diabetes Care; 1999 Mar; 22 Suppl 2():B16-20. PubMed ID: 10097894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention with nicotinamide in pre-type 1 diabetes: the Deutsche Nikotinamid Interventionsstudie-DENIS.
    Lampeter EF
    Diabete Metab; 1993; 19(1 Pt 2):105-9. PubMed ID: 8314411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
    Burkart V; Blaeser K; Kolb H
    Horm Metab Res; 1999 Dec; 31(12):641-4. PubMed ID: 10668915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.
    Masiello P; Novelli M; Fierabracci V; Bergamini E
    Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin.
    Burkart V; Wang ZQ; Radons J; Heller B; Herceg Z; Stingl L; Wagner EF; Kolb H
    Nat Med; 1999 Mar; 5(3):314-9. PubMed ID: 10086388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus].
    Rodríguez-Villar C; Conget I; Esmatjes E; Levy I; Calvet J; Figuerola D; Bergua M; Gutiérrez A; Miralles J; Millán M; Peig M; Gomis R
    Med Clin (Barc); 1996 Sep; 107(10):371-4. PubMed ID: 9036240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.
    Korkmaz A; Topal T; Oter S
    Cell Biol Toxicol; 2007 Sep; 23(5):303-12. PubMed ID: 17225077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.